129 related articles for article (PubMed ID: 17591314)
41. Successful treatment of life-threatening bleeding after cesarean section with recombinant activated factor VII.
Heilmann L; Wild C; Hojnacki B; Pollow K
Clin Appl Thromb Hemost; 2006 Apr; 12(2):227-9. PubMed ID: 16708127
[TBL] [Abstract][Full Text] [Related]
42. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
[TBL] [Abstract][Full Text] [Related]
43. Off-label use of recombinant factor VIIa in patients following bone marrow transplantation.
Blatt J; Gold SH; Wiley JM; Monahan PE; Cooper HC; Harvey D
Bone Marrow Transplant; 2001 Aug; 28(4):405-7. PubMed ID: 11571515
[TBL] [Abstract][Full Text] [Related]
44. Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII : report on one case and review of other uses in acute leukemias.
Pamuk GE; Taşçi M; Oztürk E; Demir M
Med Oncol; 2010 Mar; 27(1):16-9. PubMed ID: 19137431
[TBL] [Abstract][Full Text] [Related]
45. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery.
Raivio P; Suojaranta-Ylinen R; Kuitunen AH
Ann Thorac Surg; 2005 Jul; 80(1):66-71. PubMed ID: 15975342
[TBL] [Abstract][Full Text] [Related]
46. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
Brandsborg S; Sørensen B; Poulsen LH; Ingerslev J
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
[TBL] [Abstract][Full Text] [Related]
47. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Brenner B; Wiis J
Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
[TBL] [Abstract][Full Text] [Related]
48. Recombinant activated factor VII increases survival time in a model of incompressible arterial hemorrhage in the anesthetized pig.
Sapsford W; Watts S; Cooper G; Kirkman E
J Trauma; 2007 Apr; 62(4):868-79. PubMed ID: 17426541
[TBL] [Abstract][Full Text] [Related]
49. Recombinant factor VIIa in the treatment of bleeding.
Midathada MV; Mehta P; Waner M; Fink LM
Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
[TBL] [Abstract][Full Text] [Related]
50. Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndrome.
Ozelo MC; Svirin P; Larina L
Ann Hematol; 2005 Nov; 84(12):816-22. PubMed ID: 16044315
[TBL] [Abstract][Full Text] [Related]
51. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
Martinowitz U; Kenet G; Lubetski A; Luboshitz J; Segal E
Can J Anaesth; 2002 Dec; 49(10):S15-20. PubMed ID: 12546003
[TBL] [Abstract][Full Text] [Related]
52. Successful treatment of intractable hemothorax with recombinant factor VIIa in a nonhemophilic patient.
Wei YF; Ho CC; Lin MT; Yuan A; Yu CJ
J Formos Med Assoc; 2006 Sep; 105(9):765-9. PubMed ID: 16959626
[TBL] [Abstract][Full Text] [Related]
53. Successful treatment of massive acute lower gastrointestinal bleeding in diverticular disease of colon, with activated recombinant factor VII (NovoSeven).
Ali ZS; Al-Shaalan H; Jorgensen J
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):327-9. PubMed ID: 16651879
[TBL] [Abstract][Full Text] [Related]
54. Patient with congenital factor VII deficiency undergoing brain tumor neurosurgery successfully treated with recombinant factor VIIa and fresh frozen plasma: A case report and literature review.
Huang C; Yu Y; Zhai N; Mo W; Lin F
Medicine (Baltimore); 2023 Dec; 102(52):e36694. PubMed ID: 38206717
[TBL] [Abstract][Full Text] [Related]
55. Potential role of recombinant factor VIIa as a hemostatic agent.
Hedner U; Erhardtsen E
Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
[TBL] [Abstract][Full Text] [Related]
56. Use of recombinant activated factor VII in a patient with severe thrombocytopenia due to myelodysplastic syndrome with uncontrolled gastrointestinal bleeding.
Ozcelik T; Ozkocaman V; Ozkalemkas F; Ali R; Altundal Y; Ozkan A; Tunali A
Blood Coagul Fibrinolysis; 2007 Jun; 18(4):385-6. PubMed ID: 17473584
[No Abstract] [Full Text] [Related]
57. Recombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiency.
Tcheng WY; Donkin J; Konzal S; Wong WY
Haemophilia; 2004 May; 10(3):295-8. PubMed ID: 15086331
[TBL] [Abstract][Full Text] [Related]
58. Recombinant activated factor VII in the management of life-threatening bleeding in cardiac surgery.
Hyllner M; Houltz E; Jeppsson A
Eur J Cardiothorac Surg; 2005 Aug; 28(2):254-8. PubMed ID: 15935687
[TBL] [Abstract][Full Text] [Related]
59. [Life-threatening gastrointestinal bleeding in Crohn disease].
Farkas S; Beró T; Kersák J; Vezsenyi K
Orv Hetil; 1998 Sep; 139(38):2261-2. PubMed ID: 9775656
[TBL] [Abstract][Full Text] [Related]
60. Efficacy of recombinant activated Factor VII in patients with massive uncontrolled bleeding: a retrospective observational analysis.
Berkhof FF; Eikenboom JC
Transfusion; 2009 Mar; 49(3):570-7. PubMed ID: 19040498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
